NDC 69605-001

EVOMELA

Melphalan

EVOMELA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cenexi - Bla. The primary component is Melphalan Hydrochloride.

Product ID69605-001_d44fac6f-e1e1-399d-e053-2a95a90a81f1
NDC69605-001
Product TypeHuman Prescription Drug
Proprietary NameEVOMELA
Generic NameMelphalan
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-03-31
Marketing CategoryNDA /
Application NumberNDA207155
Labeler NameCENEXI - BLA
Substance NameMELPHALAN HYDROCHLORIDE
Active Ingredient Strength50 mg/10mL
Pharm ClassesAlkylating Activity [MoA],Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69605-001-01

1 VIAL in 1 CARTON (69605-001-01) > 20 mL in 1 VIAL
Marketing Start Date2016-03-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "EVOMELA" or generic name "Melphalan"

NDCBrand NameGeneric Name
68152-109EVOMELAMelphalan
69605-001EVOMELAMelphalan
72893-001EVOMELAMelphalan
52609-0001ALKERANmelphalan

Trademark Results [EVOMELA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EVOMELA
EVOMELA
86508057 4994159 Live/Registered
ACROTECH BIOPHARMA LLC
2015-01-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.